EXPD(EXPD)
EXPD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $11.64B | $12.00B | $12.60B |
| Low | $11.50B | $11.75B | $12.59B |
| High | $11.78B | $12.48B | $12.62B |
| EBITDA Avg | $1.31B | $1.35B | $1.42B |
| Low | $1.29B | $1.32B | $1.41B |
| High | $1.32B | $1.40B | $1.42B |
| EBIT Avg | $1.25B | $1.29B | $1.35B |
| Low | $1.24B | $1.26B | $1.35B |
| High | $1.27B | $1.34B | $1.36B |
| Net Income Avg | $895M | $898M | $966M |
| Low | $866M | $821M | $939M |
| High | $966M | $1.00B | $988M |
| EPS Avg | $6.80 | $6.84 | $7.10 |
| Low | $6.36 | $6.03 | $6.90 |
| High | $7.09 | $7.36 | $7.25 |
| Analysts (Rev / EPS) | 9 / 10 | 9 / 10 | 5 / 3 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.84B | $3.03B | $2.98B | $2.88B | $2.83B | $3.08B | $3.05B |
| Low | $2.80B | $2.94B | $2.86B | $2.76B | $2.71B | $2.95B | $2.92B |
| High | $2.90B | $3.10B | $3.15B | $3.04B | $2.98B | $3.25B | $3.22B |
| EBITDA Avg | $319M | $341M | $335M | $324M | $317M | $346M | $343M |
| Low | $314M | $331M | $321M | $310M | $304M | $332M | $329M |
| High | $326M | $348M | $353M | $341M | $335M | $365M | $361M |
| EBIT Avg | $305M | $326M | $320M | $309M | $304M | $331M | $328M |
| Low | $300M | $316M | $307M | $297M | $291M | $317M | $314M |
| High | $311M | $333M | $338M | $326M | $320M | $349M | $346M |
| Net Income Avg | $221M | $241M | $220M | $216M | $219M | $245M | $228M |
| Low | $212M | $224M | $208M | $205M | $207M | $232M | $216M |
| High | $230M | $260M | $235M | $232M | $235M | $262M | $244M |
| EPS Avg | $1.65 | $1.79 | $1.64 | $1.61 | $1.63 | $1.82 | $1.70 |
| Low | $1.58 | $1.67 | $1.55 | $1.53 | $1.55 | $1.73 | $1.61 |
| High | $1.72 | $1.94 | $1.75 | $1.73 | $1.75 | $1.95 | $1.82 |
| Analysts (Rev / EPS) | 6 / 7 | 6 / 7 | 5 / 3 | 3 / 3 | 3 / 2 | 3 / 2 | 3 / 2 |